Column: Alzheimer's drug gets FDA nod but hurdles remain
Eisai Co. and Biogen Inc.'s Alzhiemer's drug Leqembi has been granted full approval by the Food and Drug Administration, making it the first disease-slowing drug to secure that ful…
Eisai Co. and Biogen Inc.'s Alzhiemer's drug Leqembi has been granted full approval by the Food and Drug Administration, making it the first disease-slowing drug to secure that ful…